STRS Ohio’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-108,500
| Closed | -$657K | – | 1957 |
|
|
2024
Q1 | $657K | Sell |
108,500
-19,000
| -15% | -$115K | ﹤0.01% | 1085 |
|
|
2023
Q4 | $773K | Sell |
127,500
-21,300
| -14% | -$129K | ﹤0.01% | 1006 |
|
|
2023
Q3 | $627K | Sell |
148,800
-44,400
| -23% | -$187K | ﹤0.01% | 1102 |
|
|
2023
Q2 | $598K | Sell |
193,200
-30,000
| -13% | -$92.9K | ﹤0.01% | 1176 |
|
|
2023
Q1 | $310K | Hold |
223,200
| – | – | ﹤0.01% | 1496 |
|
|
2022
Q4 | $444K | Sell |
223,200
-31,500
| -12% | -$62.7K | ﹤0.01% | 1371 |
|
|
2022
Q3 | $514K | Buy |
254,700
+60,300
| +31% | +$122K | ﹤0.01% | 1320 |
|
|
2022
Q2 | $618K | Buy |
194,400
+15,500
| +9% | +$49.3K | ﹤0.01% | 1233 |
|
|
2022
Q1 | $746K | Sell |
178,900
-12,900
| -7% | -$53.8K | ﹤0.01% | 1229 |
|
|
2021
Q4 | $918K | Buy |
191,800
+32,300
| +20% | +$155K | ﹤0.01% | 1170 |
|
|
2021
Q3 | $851K | Buy |
159,500
+3,600
| +2% | +$19.2K | ﹤0.01% | 1209 |
|
|
2021
Q2 | $798K | Buy |
155,900
+26,600
| +21% | +$136K | ﹤0.01% | 1338 |
|
|
2021
Q1 | $870K | Sell |
129,300
-24,100
| -16% | -$162K | ﹤0.01% | 1253 |
|
|
2020
Q4 | $701K | Buy |
153,400
+9,300
| +6% | +$42.5K | ﹤0.01% | 1275 |
|
|
2020
Q3 | $559K | Buy |
144,100
+28,600
| +25% | +$111K | ﹤0.01% | 1258 |
|
|
2020
Q2 | $549K | Sell |
115,500
-21,000
| -15% | -$99.8K | ﹤0.01% | 1240 |
|
|
2020
Q1 | $475K | Hold |
136,500
| – | – | ﹤0.01% | 1173 |
|
|
2019
Q4 | $657K | Sell |
136,500
-46,900
| -26% | -$226K | ﹤0.01% | 1238 |
|
|
2019
Q3 | $531K | Buy |
183,400
+158,200
| +628% | +$458K | ﹤0.01% | 1241 |
|
|
2019
Q2 | $180K | Buy |
25,200
+1,800
| +8% | +$12.9K | ﹤0.01% | 1726 |
|
|
2019
Q1 | $331K | Hold |
23,400
| – | – | ﹤0.01% | 1501 |
|
|
2018
Q4 | $316K | Hold |
23,400
| – | – | ﹤0.01% | 1487 |
|
|
2018
Q3 | $519K | Sell |
23,400
-2,000
| -8% | -$44.4K | ﹤0.01% | 1365 |
|
|
2018
Q2 | $416K | Buy |
+25,400
| New | +$416K | ﹤0.01% | 1457 |
|